SEC Form D · filed November 17, 2022
A2 Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Scott Foraker · Agoura Hills, CAExec · DirectorJakob S. Loven · Agoura Hills, CADirectorMadhavan Balachandran · Agoura Hills, CADirectorThomas S. Leung · Agoura Hills, CAExecSrini Akkaraju · Agoura Hills, CADirectorDavid S. Lucas · Agoura Hills, CAExecHelen S. Kim · Agoura Hills, CADirectorSusan L. Kelley · Agoura Hills, CADirectorDavid Goeddel · Agoura Hills, CADirectorAlexander Kamb · Agoura Hills, CAExec · DirectorWilliam S. Go · Agoura Hills, CAExecGriffin Davis · Tysons, VAExecAnthony Avila · Corte Madera, CADirectorCroatan Investment Management LLC · VIRGINIA BEACH, VADirectorScott T. Harris · Dallas, TXExecOscar Vasquez · Corte Madera, CAExecHouman Ashrafian · London, United KingdomDirectorJonathan Behr · London, United KingdomExec · DirectorRalph Achacoso · Stamford, CTDirectorJason Zhang · Stamford, CTDirectorKate Bingham · London, United KingdomDirectorRussell T. Shattan · Dallas, TXExec · DirectorJames Gibson · Excelsior, MNExec · DirectorJohn Menzies · Austin, TXDirectorKevin Puil · Austin, TXDirectorDaniel Gay · BOSTON, MADirectorDaniel Armbrust · Santa Clara, CADirectorJohn Provine · Santa Clara, CADirectorArun Gollakota · New York, NYExecSteve Kreidler · Golden, CODirectorSherman Ragland · Upper Marlboro, MDExecJw Roth · Colorado Springs, COExecChristopher T. Russo · Lancaster, PAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗